<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02804633</url>
  </required_header>
  <id_info>
    <org_study_id>JH 13-04</org_study_id>
    <nct_id>NCT02804633</nct_id>
  </id_info>
  <brief_title>Decrease Opioid Consumption With Intra-Venous (IV) Acetaminophen After Colorectal Surgery (DOCIVA)</brief_title>
  <acronym>DOCIVA</acronym>
  <official_title>Decreased Opioid Consumption and Enhance Recovery With the Addition of IV-Acetaminophen in Colorectal Patients: A Prospective, Randomized, Double-Blinded, Placebo-Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jewish Hospital, Cincinnati, Ohio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jewish Hospital, Cincinnati, Ohio</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesis is that use of IV acetaminophen will significantly decrease use&#xD;
      of post-operative opioid consumption and enhances recovery after colorectal surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients undergoing laparoscopic and open colorectal surgery are randomized to receive&#xD;
      either IV acetaminophen or placebo. All patients received an opioid patient controlled&#xD;
      anesthesia (PCA). IV acetaminophen (1 gram) or placebo is given 30 minutes prior to operation&#xD;
      and every 6 hours thereafter for up to 5 days post-operatively or discharge.&#xD;
&#xD;
      The investigators primary endpoint is to evaluate opioid consumption during the patient's&#xD;
      hospital stay. The investigators secondary endpoints are to evaluate return of&#xD;
      gastrointestinal function (ROGIF), time to diet ordered (TTDO), length of hospital stay&#xD;
      (LOHS) and occurrence of ileus. Pain is measured with the pain visual analog scale score&#xD;
      (PVASS) at 3, 8, 24 and 48 hours.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total opioid consumption</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>pain control base on pain visual Analogue Scale Score (1-10)</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>time to Return of GI function (ROGIF) [Flatus or bowel movement]</measure>
    <time_frame>through study completion, an average of 5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to diet ordered (TTDO)</measure>
    <time_frame>through study completion, an average of 5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay (LOHS)</measure>
    <time_frame>through study completion, an average of 5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of ileus</measure>
    <time_frame>through study completion, an average of 5 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">105</enrollment>
  <condition>Pain Control Post Colorectal Surgery</condition>
  <arm_group>
    <arm_group_label>IV acetaminophen group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In addition to PCA (morphine or hydromorphone) all patients receive 1 gram of IV acetaminophen (100 ml ) 30 minutes prior to operation and every 6 hours thereafter for up to 5 days post-operatively or discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In addition to PCA (morphine or hydromorphone) all patients received placebo (100 ml normal saline) given 30 minutes prior to operation and every 6 hours thereafter for up to 5 days post-operatively or discharge</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV Acetaminophen</intervention_name>
    <description>1 gram every 6 hours</description>
    <arm_group_label>IV acetaminophen group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>100 ml of normal saline every 6 hours</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient undergoing colorectal operation (Hartmann's procedure, sigmoidectomy, left&#xD;
             hemicolectomy, right hemicolectomy, transverse colectomy, ileocecectomy, colo-colonic&#xD;
             anastomosis, colorectal anastomosis, ileo-colonic anastomosis, low anterior resection,&#xD;
             or abdominoperineal resection)&#xD;
&#xD;
          -  Age range from 18 to 90 years old&#xD;
&#xD;
          -  Patient providing signed, written informed consent before participation in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient younger than 18 years old or older than 90 years old&#xD;
&#xD;
          -  Patient or family is unable to give consent&#xD;
&#xD;
          -  Patient who use opioids or tramadol daily for &gt;7 days before study medication&#xD;
             administration(patient who, in the investigator's opinion, had or was developing&#xD;
             opioid tolerance)&#xD;
&#xD;
          -  Patient who had a chronic pain condition or any significant medical disease,&#xD;
             laboratory abnormality, or condition that, in the investigator's judgment, could have&#xD;
             compromised the subject's welfare, ability to communicate with the study staff,&#xD;
             complete study activities, or otherwise restricted study participation&#xD;
&#xD;
          -  Patient who had hypersensitivity to opioids, acetaminophen, or the inactive&#xD;
             ingredients of the study medication&#xD;
&#xD;
          -  Patient who had known or suspected history of alcohol or drug abuse or dependence&#xD;
             within the previous 1 year&#xD;
&#xD;
          -  Patient who had impaired liver function&#xD;
&#xD;
          -  Patient who had fever within first 48 hours post-operatively and required&#xD;
             acetaminophen for fever reduction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2016</verification_date>
  <study_first_submitted>June 8, 2016</study_first_submitted>
  <study_first_submitted_qc>June 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2016</study_first_posted>
  <last_update_submitted>June 14, 2016</last_update_submitted>
  <last_update_submitted_qc>June 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jewish Hospital, Cincinnati, Ohio</investigator_affiliation>
    <investigator_full_name>Amir H. Aryaie</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>IV acetaminophen</keyword>
  <keyword>Colorectal Surgery</keyword>
  <keyword>Enhance Recovery</keyword>
  <keyword>Opioid Consumption</keyword>
  <keyword>Pain Management</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

